financetom
Business
financetom
/
Business
/
Analog Devices Launches Sensinel Cardiopulmonary Management System Following FDA Clearance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Analog Devices Launches Sensinel Cardiopulmonary Management System Following FDA Clearance
Mar 5, 2024 7:29 AM

10:06 AM EST, 03/05/2024 (MT Newswires) -- Analog Devices ( ADI ) said Tuesday that it has commercially launched its Sensinel cardiopulmonary management system after securing the US Food and Drug Administration's clearance for the wearable device.

The company said Sensinel captures cardiopulmonary measurements for management of chronic disease such as heart failure.

Price: 194.19, Change: -0.47, Percent Change: -0.24

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved